Clera Healthcare Ltd is a UK-based company founded in March 2023, specializing in enhancing communication between healthcare teams and patients' families. The company aims to ensure that every patient receives the communication and compassion they deserve while alleviating the pressures on healthcare professionals. By leveraging secure and efficient communication platforms, Clera Healthcare seeks to bridge the information gap in hospital settings, thereby improving patient and family satisfaction.
Key Strategic Focus
Clera Healthcare's primary objective is to streamline and secure communication channels within healthcare environments. The company focuses on developing platforms that enable healthcare teams to provide timely updates to patients and their families, reducing misunderstandings and enhancing overall care experiences. By addressing the critical need for effective communication in hospitals, Clera Healthcare positions itself as a pivotal player in improving patient engagement and satisfaction.
Financials and Funding
As of June 30, 2024, Clera Healthcare reported total assets of £77,380 and total liabilities of £17,520, resulting in net assets of £59,860. The company held £7,170 in cash reserves. These financials reflect the early-stage nature of the company, with a focus on developing its platform and establishing a market presence.
Technological Platform and Innovation
Clera Healthcare emphasizes data security and compliance in its technological offerings. Recognizing the legal challenges associated with using non-secure channels like WhatsApp for patient information, the company has partnered with security specialists to ensure that its communication platforms meet stringent healthcare security standards. This commitment to secure and compliant communication solutions sets Clera Healthcare apart in the industry.
Leadership Team
The company is led by co-founders Dr. Alice Appleton and Dr. Jonathan Abeles, both practicing doctors in the NHS. Their firsthand experience with the challenges of patient communication in hospital settings inspired the creation of Clera Healthcare. Their medical backgrounds provide valuable insights into the needs of healthcare professionals and patients, guiding the development of the company's solutions.
Strategic Collaborations and Partnerships
Clera Healthcare has established several key partnerships to bolster its platform development and market reach:
- ASquared: Acting as the fractional CTO and CDO, ASquared has been instrumental in Clera Healthcare's technological development.
- Ghyston: A Bristol-based software development company collaborating closely with Clera Healthcare to enhance product offerings.
- SETSquared Bristol: As part of the FWD program, Clera Healthcare benefits from this health technology-specific incubator and support network.
- Health Innovation Network: The Kent Surrey Sussex HIN provides ongoing support in NHS innovation, assisting in finding partners and NHS trust pilot sites.
- Hobbs Rehabilitation: Partnered to trial Clera's platform within three neurorehabilitation inpatient units in early 2024.
- Clinical Entrepreneur Programme: Both co-founders are fellows on cohort 8 of the CEP, an NHS workforce development program supporting clinicians in building companies and developing innovations.
- Milton Keynes Investor Group: Recipient of a £7,000 MKIG tech fund grant in March 2024, supporting innovation in the Milton Keynes area.
- UnLtd Award: Received grant funding from UnLtd, aiding in launching the first NHS pilot and benefiting from mentoring and tailored business advice.
Strategic Opportunities and Future Directions
Clera Healthcare is poised to expand its platform's adoption across NHS trusts and private healthcare providers. By continuously enhancing its technology and forging strategic partnerships, the company aims to become a leader in healthcare communication solutions, ultimately improving patient outcomes and satisfaction.
